High-Dose [131I]Tositumomab (anti-CD20) Radioimmunotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Adults ≥ 60 Years Old With Relapsed or Refractory B-Cell Lymphoma Forty-nine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback